Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-22-005187
Filing Date
2022-07-28
Accepted
2022-07-28 17:14:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm DEFA14A 20589
2 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 31333
3 GRAPHIC image_001.jpg GRAPHIC 4997
  Complete submission text file 0001683168-22-005187.txt   60139
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-40699 | Film No.: 221116220
SIC: 2836 Biological Products, (No Diagnostic Substances)